Similar results were obtained among CFH polymorphism carriers with no differences between low-risk (CFH 402YY), heterozygous high-risk (CFH 402YH), or homozygous high-risk (CFH 402HH) allele carriers in AMD patients. The gene discussed is CFH; the disease is age-related macular degeneration.